# EDGAR Filing Document

**Accession Number:** 0001038133
**File Stem:** 0001038133-23-000002
**Filing Date:** 2023-2
**Character Count:** 8091
**Document Hash:** adbd8c13c5db797f8105464152609973
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001038133-23-000002.hdr.sgml**: 20230201

**ACCESSION NUMBER**: 0001038133-23-000002

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230127

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230201

**DATE AS OF CHANGE**: 20230201

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HESKA CORP
- **CENTRAL INDEX KEY:** 0001038133
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 770192527
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-22427
- **FILM NUMBER:** 23577121

**BUSINESS ADDRESS:**
- **STREET 1:** 3760 ROCKY MOUNTAIN AVENUE
- **CITY:** LOVELAND
- **STATE:** CO
- **ZIP:** 80538
- **BUSINESS PHONE:** 9704937272

**MAIL ADDRESS:**
- **STREET 1:** 3760 ROCKY MOUNTAIN AVENUE
- **CITY:** LOVELAND
- **STATE:** CO
- **ZIP:** 80538

?xml version="1.0" ? hska-20230127

---

| | | |
|:---|:---|:---|
| **UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION** | **UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION** | **UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION** |
| **Washington, D.C. 20549** | **Washington, D.C. 20549** | **Washington, D.C. 20549** |
| **FORM 8-K** | **FORM 8-K** | **FORM 8-K** |
| (Amendment No.) | (Amendment No.) | (Amendment No.) |
| **CURRENT REPORT** | **CURRENT REPORT** | **CURRENT REPORT** |
| **Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934** | **Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934** | **Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934** |
| **January 27, 2023**<br>Date of Report (Date of earliest event reported) | **January 27, 2023**<br>Date of Report (Date of earliest event reported) | **January 27, 2023**<br>Date of Report (Date of earliest event reported) |
| **HESKA CORPORATION**<br>(Exact name of Registrant as specified in its charter) | **HESKA CORPORATION**<br>(Exact name of Registrant as specified in its charter) | **HESKA CORPORATION**<br>(Exact name of Registrant as specified in its charter) |
| **Delaware** | **000-22427** | **77-0192527** |
| (State or other jurisdiction of<br>incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| **3760 Rocky Mountain Avenue**<br>**Loveland, Colorado**<br>(Address of principal executive offices) | **3760 Rocky Mountain Avenue**<br>**Loveland, Colorado**<br>(Address of principal executive offices) | **80538**<br>(Zip Code) |
| Registrant's telephone number, including area code | Registrant's telephone number, including area code | **(970) 493-7272** |
| **Not Applicable**<br>(Former name or former address, if changed since last report) | **Not Applicable**<br>(Former name or former address, if changed since last report) | **Not Applicable**<br>(Former name or former address, if changed since last report) |
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below): | Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below): | Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below): |
| ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.01 par value | HSKA | The Nasdaq Stock Market LLC |
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
| Emerging Growth Company ☐ | Emerging Growth Company ☐ | Emerging Growth Company ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □ |

---

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On January 27, 2023, Nancy Wisnewski, Ph.D., Executive Vice President, Chief Operating Officer of Heska Corporation (the "Company"), informed the Company that after more than 30 years of service, she will step down from such position effective March 31, 2023. Dr. Wisnewski will remain with the Company in the position of Chief Science Advisor to the CEO. The Company expects to prepare operational team leadership changes in advance of the transition that begins March 31st.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | HESKA CORPORATION,<br>a Delaware corporation |
| Dated: February 1, 2023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Christopher Sveen</u><br>&nbsp;&nbsp;&nbsp;&nbsp; Christopher Sveen<br>*Executive Vice President, Chief Administrative Officer and General Counsel* |

---